Oncology Laboratory, Institute of Experimental Medicine and Biology of Cuyo (IMBECU), Scientific and Technological Center (CCT), CONICET, 5500 Mendoza, Argentina.
Apoptosis Cancer and Development, Cancer Research Center of Lyon (CRCL), UMR INSERM 1052-CNRS 5286, Claude Bernard University, Lyon-1, Cheney A Building, Centre Regional Léon Bérard, 28, rue Laennec 69008 LYON, France.
Arch Toxicol. 2013 Jan;87(1):19-48. doi: 10.1007/s00204-012-0918-z. Epub 2012 Aug 11.
Heat shock proteins (HSP) are a subset of the molecular chaperones, best known for their rapid and abundant induction by stress. HSP genes are activated at the transcriptional level by heat shock transcription factor 1 (HSF1). During the progression of many types of cancer, this heat shock transcriptional regulon becomes co-opted by mechanisms that are currently unclear, although evidently triggered in the emerging tumor cell. Concerted activation of HSF1 and the accumulation of HSPs then participate in many of the traits that permit the malignant phenotype. Thus, cancers of many histologies exhibit activated HSF1 and increased HSP levels that may help to deter tumor suppression and evade therapy in the clinic. We review here the extensive work that has been carried out and is still in progress aimed at (1) understanding the oncogenic mechanisms by which HSP genes are switched on, (2) determining the roles of HSF1/HSP in malignant transformation and (3) discovering approaches to therapy based on disrupting the influence of the HSF1-controlled transcriptome in cancer.
热休克蛋白(HSP)是分子伴侣的一个子集,以其对压力的快速大量诱导而闻名。HSP 基因在转录水平上通过热休克转录因子 1(HSF1)激活。在许多类型癌症的发展过程中,这个热休克转录调节因子被目前尚不清楚的机制所篡夺,尽管显然是在新出现的肿瘤细胞中触发的。HSF1 的协同激活和 HSP 的积累参与了许多允许恶性表型的特征。因此,许多组织学类型的癌症都表现出激活的 HSF1 和增加的 HSP 水平,这可能有助于阻止肿瘤抑制并逃避临床治疗。我们在这里回顾了已经进行和正在进行的广泛工作,旨在(1)了解 HSP 基因被开启的致癌机制,(2)确定 HSF1/HSP 在恶性转化中的作用,以及(3)发现基于破坏 HSF1 控制的转录组在癌症中的影响的治疗方法。